Loading...
Dose‐Response Analysis of the Effect of Carbidopa‐Levodopa Extended‐Release Capsules (IPX066) in Levodopa‐Naive Patients With Parkinson Disease
Parkinson disease is an age‐related disorder of the central nervous system principally due to loss of dopamine‐producing cells in the midbrain. Levodopa, in combination with carbidopa, is widely regarded as an effective treatment for the symptoms of Parkinson disease. A dose‐response relationship is...
Saved in:
| Published in: | J Clin Pharmacol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066683/ https://ncbi.nlm.nih.gov/pubmed/26632091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.683 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|